Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey

Fig. 1

Total and LDL cholesterol changes in HoFH according to lipid-lowering therapies. Box plot graphs represent median values of TC and LDL-Cs. Lipid values are shown in 4 different shades of green corresponding to the untreated, lowest on conventional LLT, baseline (before initiation of lomitapide or LA treatment) and at last visit measurements. For the definition of untreated, lowest values on conventional LLT, baseline and last visit see Material and Methods. In A are reported data observed in the lomitapide cohort whereas in B those in the LA cohort. LDL-C, low density lipoprotein cholesterol; LLT, lipid-lowering therapy; LA, lipoprotein apheresis; NS, not significant

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172